Covered recipient · General Payments record
RYAN N CHAUVIN
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,190.20
- Reported across 148 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $462.15 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $216.15 | 22 |
| GENZYME CORPORATION | $78.77 | 4 |
| PFIZER INC. | $64.68 | 4 |
| Medtronic, Inc. | $32.30 | 2 |
| Janssen Biotech, Inc. | $21.06 | 1 |
| Celgene Corporation | $19.75 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.95 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $14.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.48 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449122 | CMS |
| ABBVIE INC. | $0.80 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449124 | CMS |
| ABBVIE INC. | $16.92 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449126 | CMS |
| ABBVIE INC. | $33.67 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449128 | CMS |
| ABBVIE INC. | $12.33 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449130 | CMS |
| ABBVIE INC. | $16.14 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449132 | CMS |
| ABBVIE INC. | $2.45 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449134 | CMS |
| ABBVIE INC. | $11.13 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449136 | CMS |
| ABBVIE INC. | $8.47 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449138 | CMS |
| ABBVIE INC. | $12.66 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449140 | CMS |
| ABBVIE INC. | $1.13 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449142 | CMS |
| ABBVIE INC. | $9.13 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449144 | CMS |
| ABBVIE INC. | $4.46 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449146 | CMS |
| ABBVIE INC. | $6.52 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449148 | CMS |
| ABBVIE INC. | $12.70 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449150 | CMS |
| ABBVIE INC. | $1.78 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449152 | CMS |
| ABBVIE INC. | $15.53 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449154 | CMS |
| ABBVIE INC. | $7.24 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449156 | CMS |
| ABBVIE INC. | $17.18 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449158 | CMS |
| ABBVIE INC. | $4.16 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449160 | CMS |
| ABBVIE INC. | $0.69 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449162 | CMS |
| ABBVIE INC. | $6.58 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103449164 | CMS |
| Boston Scientific Corporation | $14.49 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092587945 | CMS |
| Celgene Corporation | $19.75 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101077056 | CMS |
| GENZYME CORPORATION | $17.02 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139973155 | CMS |
| GENZYME CORPORATION | $23.86 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139973157 | CMS |
| GENZYME CORPORATION | $20.00 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139973159 | CMS |
| GENZYME CORPORATION | $17.89 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139973161 | CMS |
| Janssen Biotech, Inc. | $21.06 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078667554 | CMS |
| Medtronic, Inc. | $13.70 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119308284 | CMS |
| Medtronic, Inc. | $18.60 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119308286 | CMS |
| PFIZER INC. | $17.99 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131116093 | CMS |
| PFIZER INC. | $18.37 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131191822 | CMS |
| PFIZER INC. | $13.70 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131955586 | CMS |
| PFIZER INC. | $14.62 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132099195 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.95 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137508602 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.